Planet Briefing

First published · Last updated

Construction of efficacy prediction model for T-DXd treatment of HER2-positive and HER2-low expression breast cancer based on hematological indicators: A real-world study

A real-world journal article reports construction of an efficacy prediction model for T-DXd treatment of HER2-positive and HER2-low expression breast cancer using hematological indicators. Publisher is listed as Elsevier BV and publication date is 2027-02-01.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
2/10
Geographic reach
1/10
Global importance
3/10
Impact magnitude
3/10
Positivity
7/10
Urgency
2/10

Why it matters

The study presents a predictive model for efficacy of T-DXd treatment in HER2-positive and HER2-low breast cancer.

Sources

Report an issue